These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 29025634)
21. Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study. Hartner AM; Li X; Echeverria-Londono S; Roth J; Abbas K; Auzenbergs M; de Villiers MJ; Ferrari MJ; Fraser K; Fu H; Hallett T; Hinsley W; Jit M; Karachaliou A; Moore SM; Nayagam S; Papadopoulos T; Perkins TA; Portnoy A; Minh QT; Vynnycky E; Winter AK; Burrows H; Chen C; Clapham HE; Deshpande A; Hauryski S; Huber J; Jean K; Kim C; Kim JH; Koh J; Lopman BA; Pitzer VE; Tam Y; Lambach P; Sim SY; Woodruff K; Ferguson NM; Trotter CL; Gaythorpe KAM Lancet Glob Health; 2024 Apr; 12(4):e563-e571. PubMed ID: 38485425 [TBL] [Abstract][Full Text] [Related]
22. Empirical estimation of resource constraints for use in model-based economic evaluation: an example of TB services in South Africa. Bozzani FM; Mudzengi D; Sumner T; Gomez GB; Hippner P; Cardenas V; Charalambous S; White R; Vassall A Cost Eff Resour Alloc; 2018; 16():27. PubMed ID: 30069166 [TBL] [Abstract][Full Text] [Related]
23. Public engagement to refine a whole-school intervention to promote adolescent mental health. Bonell C; Hope S; Sundaram N; Lloyd-Houldey O; Michalopoulou S; Scott S; Nicholls D; Viner R Public Health Res (Southampt); 2024 Dec; ():1-22. PubMed ID: 39636228 [TBL] [Abstract][Full Text] [Related]
24. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study. Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843 [TBL] [Abstract][Full Text] [Related]
25. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT. Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608 [TBL] [Abstract][Full Text] [Related]
26. The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries. Portnoy A; Clark RA; Weerasuriya CK; Mukandavire C; Quaife M; Bakker R; Garcia Baena I; Gebreselassie N; Zignol M; Jit M; White RG; Menzies NA BMJ Glob Health; 2023 Jul; 8(7):. PubMed ID: 37438049 [TBL] [Abstract][Full Text] [Related]
27. Accuracy of the Wound Healing Questionnaire in the diagnosis of surgical-site infection after abdominal surgery in low- and middle-income countries. NIHR Global Health Research Unit on Global Surgery Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38747515 [TBL] [Abstract][Full Text] [Related]
28. Interventions to enhance corporate sector engagement in tuberculosis response in Africa: a scoping review protocol. Ogbodu OM; Mrara B; Oladimeji O BMJ Open; 2024 Dec; 14(12):e089472. PubMed ID: 39638599 [TBL] [Abstract][Full Text] [Related]
29. The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. GBD 2021 US Burden of Disease Collaborators Lancet; 2024 Dec; 404(10469):2314-2340. PubMed ID: 39645376 [TBL] [Abstract][Full Text] [Related]
30. Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis. Edwards SJ; Karner C; Jhita T; Barton S; Marceniuk G; Yiu ZZN; Wittmann M Health Technol Assess; 2024 Jan; 28(4):1-113. PubMed ID: 38343072 [TBL] [Abstract][Full Text] [Related]
31. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Clark A; Jit M; Warren-Gash C; Guthrie B; Wang HHX; Mercer SW; Sanderson C; McKee M; Troeger C; Ong KL; Checchi F; Perel P; Joseph S; Gibbs HP; Banerjee A; Eggo RM; Lancet Glob Health; 2020 Aug; 8(8):e1003-e1017. PubMed ID: 32553130 [TBL] [Abstract][Full Text] [Related]
32. Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study. Dorward J; Sookrajh Y; Khubone T; van der Molen J; Govender R; Phakathi S; Lewis L; Bottomley C; Maraj M; Lessells RJ; Naidoo K; Butler CC; Van Heerden R; Garrett N Lancet HIV; 2023 May; 10(5):e284-e294. PubMed ID: 37001536 [TBL] [Abstract][Full Text] [Related]
33. Global, regional, and national trends in under-5 mortality between 1990 and 2019 with scenario-based projections until 2030: a systematic analysis by the UN Inter-agency Group for Child Mortality Estimation. Sharrow D; Hug L; You D; Alkema L; Black R; Cousens S; Croft T; Gaigbe-Togbe V; Gerland P; Guillot M; Hill K; Masquelier B; Mathers C; Pedersen J; Strong KL; Suzuki E; Wakefield J; Walker N; Lancet Glob Health; 2022 Feb; 10(2):e195-e206. PubMed ID: 35063111 [TBL] [Abstract][Full Text] [Related]
34. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication. Ryan R; Hill S Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081 [TBL] [Abstract][Full Text] [Related]
35. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection. Abbas K; Procter SR; van Zandvoort K; Clark A; Funk S; Mengistu T; Hogan D; Dansereau E; Jit M; Flasche S; Lancet Glob Health; 2020 Oct; 8(10):e1264-e1272. PubMed ID: 32687792 [TBL] [Abstract][Full Text] [Related]
36. Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets. Mihaylova B; Wu R; Zhou J; Williams C; Schlackow I; Emberson J; Reith C; Keech A; Robson J; Parnell R; Armitage J; Gray A; Simes J; Baigent C Health Technol Assess; 2024 Dec; 28(79):1-134. PubMed ID: 39644281 [TBL] [Abstract][Full Text] [Related]
37. Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling study. Puett C; Anderson JD; Bagamian KH; Muhib F; Scheele S; Hausdorff WP; Pecenka C Lancet Glob Health; 2023 Jun; 11(6):e892-e902. PubMed ID: 37202024 [TBL] [Abstract][Full Text] [Related]
38. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators Lancet; 2018 Nov; 392(10159):1789-1858. PubMed ID: 30496104 [TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study. Phillips AN; Bershteyn A; Revill P; Bansi-Matharu L; Kripke K; Boily MC; Martin-Hughes R; Johnson LF; Mukandavire Z; Jamieson L; Meyer-Rath G; Hallett TB; Ten Brink D; Kelly SL; Nichols BE; Bendavid E; Mudimu E; Taramusi I; Smith J; Dalal S; Baggaley R; Crowley S; Terris-Prestholt F; Godfrey-Faussett P; Mukui I; Jahn A; Case KK; Havlir D; Petersen M; Kamya M; Koss CA; Balzer LB; Apollo T; Chidarikire T; Mellors JW; Parikh UM; Godfrey C; Cambiano V; Lancet HIV; 2022 May; 9(5):e353-e362. PubMed ID: 35489378 [TBL] [Abstract][Full Text] [Related]
40. Disparities in wellbeing in the USA by race and ethnicity, age, sex, and location, 2008-21: an analysis using the Human Development Index. Dwyer-Lindgren L; Kendrick P; Baumann MM; Li Z; Schmidt C; Sylte DO; Daoud F; La Motte-Kerr W; Aldridge RW; Bisignano C; Hay SI; Mokdad AH; Murray CJL Lancet; 2024 Dec; 404(10469):2261-2277. PubMed ID: 39522526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]